Metastasis - The role of tumour cells aggregation with platelets;Przerzut nowotworowy - Znaczenie agregacji komórek nowotworowych z płytkami krwi

Onkologia Polska

Volumn 8, Issue 4, 2005, Pages 229-238

  Paduch, Roman ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Endothelium; Metastasis; Platelets; Tumour

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANGIOGENESIS; CANCER CELL; CANCER MORTALITY; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FIBRIN DEPOSITION; HUMAN; LEUKOCYTE COUNT; METASTASIS; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; TUMOR CELL; TUMOR GROWTH;

EID: 33644935986     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Balkwill F.: Chemokine biology in cancer. Semin. Immunol. 2003, 15, 49-55.
2. Kuppen P.J.K., van der Eb M.M., Jonges L.E. i wsp.: Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem. Cell Biol. 2001, 115, 67-72.
3. Ribatti D., Vacca A., Dammacco F.: New nonangiogenesis dependent pathways for tumour growth. Eur. J. Cancer 2003, 39, 1835-1841.
4. Griggs J., Metcalfe J.C., Hesketh R.: Targeting tumour vasculature: the development of combretastatin A4. Lancet Oncol. 2001, 2, 82-87.
5. Pinedo H.M., Verheul H.M.W., D'Amato R.J., Folkman J.: Involvement of platelets in tumour angiogenesis? Lancet 1998, 352, 1775-1777.
6. Akashi T., Furuya Y., Ohta S., Fuse H.: Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology 2003, 62, 1078-1082.
7. Förster Y., Meye A.,Albrecht S. i wsp.: Tissue specyfic expression and serum levels of human tissue factor in patients with urological cancer. Cancer Lett. 2003, 193, 65-73.
8. Lwaleed B.A., Cooper A.J.: Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu. Med. Hypotheses 2000, 55, 470-473.
9. Rickles F.R., Patierno S., Fernandez P.M.: Tissue factor, thrombin, and cancer. Chest 2003, 124, 58S-68S.
10. Fernandez P.M., Patierno S.R., Rickles F.R.: Tissue factor and fibrin in tumor angiogenesis. Semin. Thromb. Hemost. 2004, 30, 31-44.
11. Nash G.F., Walsh D.C., Kakkar A.K.: The role of the coagulation system in tumour angiogenesis. Lancet Oncol. 2001, 2, 608-613.
12. Nash G.F., Turner L.F., Scully M.F., Kakkar AK.: Platelets and cancer. Lancet Oncol. 2002, 3, 425-430.
13. Biggerstaff J.P., Seth N., Amirkhosravi A. i wsp.: Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis. Clin. Exp. Metastasis 1999, 17, 723-730.
14. Biggerstaff J.P., Seth N.B., Meyer T.V. i wsp.: Fibrin monomer increases platelet adherence to tumor cells in a flowing system: a possible role in metastasis? Thromb. Res. 1998, 92, S53-S58.
15. Molema G., Meijer D.K.F., de Leij L.F.M.H.: Tumor vasculature targeted therapies. Biochem. Pharmacol. 1998, 55, 1939-1945.
16. Baban D. F. Seymour L.W.: Control of tumour vascular permeability. Adv. Drug Deliv. Rev. 1998, 34, 109-119.
17. Böhle A.S., Kalthoff H.: Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch. Surg. 1999, 384, 133-140.
18. Jakóbisiak M.: Immunologia. Wydawnictwo Naukowe PWN, Warszawa 1995.
19. Hejna M., Raderer M., Zielinski CC.: Inhibition of metastases by anticoagulants. J. Natl. Cancer Inst. 1999, 91, 22-36.
20. Honn K.V., Tang D.G., Crissman J.D.: Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 1992, 3-4, 325-351.
21. Koike C., Watanabe M., Isoai A. i wsp.: How platelet aggregation affects B16BL6 melanoma cell trafficking. FEBS Lett. 1998, 427, 286-290.
22. Nieswandt B., Hafner M., Echtenacher B., Männel D.N.: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 1999, 59, 1295-1300.
23. Borsig L., Wong R., Hynes R.O. i wsp.: Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. USA 2002, 99, 2193-2198.
24. Borsig L.: Non-anticoagulant effects of heparin in carcinoma metastasis and Trousseau's syndrome. Pathophysiol. Haemost. Thromb. 2003, 33, suppl. 1, 64-66.
25. Yu Y., Zhou X.-D., Liu Y.-K. i wsp.: Platelets promote the adhesion of human hepatoma cells with a highly metastatic potential to extracellular matrix protein: involvement of platelet P-selectin and GP IIb-IIIa. J. Cancer Res. Clin. Oncol. 2002, 128, 283-287.
26. Fang L.-H., Lucero M., Kazarian T. i wsp.: Effect of neuroblastoma tumor gangliosides on platelet adhesion to collagen. Clin. Exp. Metastasis 1997, 15, 33-40.
27. Damin D.C., Rosito MA., Gus P. i wsp.: Von Willebrand factor in colorectal cancer. Int. J. Colorectal. Dis. 2002, 17, 42-45.
28. Borsig L., Wong R., Feramisco J. i wsp.: Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. USA 2001, 98, 3352-3357.
29. Butler P.C., Potter G.A.: Non-haematological solid tumours as surrogate granulocytes: a possible mechanism for metastatic spread. Med. Hypothesis 2001, 56, 625-628.
30. Thorlacius H., Prieto J., Raud J. i wsp.: Tumor cell arrest in the microcirculation: lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo. Clin. Immunol. Immunopathol. 1997, 83, 68-76.
31. Kannagi R.: Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj. J. 1997, 14, 577-584.
32. Offner F.A., Bigalke I., Schiefer J. i wsp.: Interaction of human mallgnant melanoma tumor spheroids with endothelium and reconstitued basement membrane: modulation by RGDS. Int. J. Cancer 1993, 54, 506-612.
33. McEver R.P.: Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj. J. 1997, 14, 585-591.
34. Voura E.B., Sandig M., Siu Ch-H.: Cell-cell interactions during transendothellal migration of tumor cells. Microsc. Res. Tech. 1998, 43, 265-275.
35. Blood C.H., Zetter B.R.: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta 1990, 1032, 89-118.
36. Bussemakers M.J.G., Schalken J.A.: The role of adhesion molecules and proteases in tumor invasion and metastasis. World J. Urol. 1996, 14, 151-156.
37. Powell W.C., Matrisian L.M.: Complex roles of matrix metalloproteinases in tumor progression. Curr. Topics Microb. Immunol. 1996, 213, 1-21.
38. Sawicki G., Radomski M.W.: Nowe aspekty biologii metaloproteinaz przestrzeni miedzykomórkowej (MMPs). Diagn. Lab 1999, 35, 373-380.
39. Chambers A.F., Matrisian L.M.: Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 1997, 89, 1260-1270.
40. Meyer T., Hart I.R.: Mechanisms of tumour metastasis. Eur. J. Cancer 1998, 34, 214-221.
41. Patterson B.C., Sang Q.A.: Angiostatin-converting enzyme activities of human matrylisin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 1997, 272, 28823-28825.
42. Streuli C.: Extracellular matrix remodelling and cellular differentation. Curr. Opin. Cell Biol. 1999, 11, 634-640.
43. Desai S.B., Libutti S.K.: Tumor angiogenesis and endothelial cell modulatory factors. J. Immunother. 1999, 22, 186-211.
44. Moses M.A.: The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 1997, 15, 180-189.
45. Woessner J.F.: Matrix metalloproteinases and their inhibitors in concective tissue remodelling. FASEB J. 1991, 5, 2145-2154.